Segev Barak
Segev Barak
School of Psychological Sciences and the Sagol School of Neuroscience, Tel Aviv University
Verified email at post.tau.ac.il - Homepage
TitleCited byYear
Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse
S Carnicella, D Ron, S Barak
Alcohol 48 (3), 243-252, 2014
1622014
Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse
S Barak, F Liu, SB Hamida, QV Yowell, J Neasta, V Kharazia, PH Janak, ...
Nature neuroscience 16 (8), 1111, 2013
1142013
Chromatin remodeling—a novel strategy to control excessive alcohol drinking
V Warnault, E Darcq, A Levine, S Barak, D Ron
Translational psychiatry 3 (2), e231-e231, 2013
1032013
Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat
MD Black, GB Varty, M Arad, S Barak, A De Levie, D Boulay, P Pichat, ...
Psychopharmacology 202 (1-3), 385-396, 2009
882009
Molecular mechanisms underlying alcohol-drinking behaviours
D Ron, S Barak
Nature Reviews Neuroscience 17 (9), 576, 2016
792016
Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seeking
S Barak, S Carnicella, QV Yowell, D Ron
Journal of Neuroscience 31 (27), 9885-9894, 2011
752011
mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse
J Neasta, S Barak, SB Hamida, D Ron
Journal of neurochemistry 130 (2), 172-184, 2014
712014
Corticostriatal BDNF and alcohol addiction
ML Logrip, S Barak, V Warnault, D Ron
Brain research 1628, 60-67, 2015
612015
Pro-cognitive and antipsychotic efficacy of the α 7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia
S Barak, M Arad, A De Levie, MD Black, G Griebel, I Weiner
Neuropsychopharmacology 34 (7), 1753-1763, 2009
582009
AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side …
MD Black, RJ Stevens, N Rogacki, RE Featherstone, Y Senyah, ...
Psychopharmacology 215 (1), 149-163, 2011
462011
Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor
S Barak, I Weiner
Neuropsychopharmacology 32 (5), 989-999, 2007
452007
Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndrome
S Barak
Behavioural brain research 204 (2), 335-351, 2009
442009
Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target
S Barak, I Weiner
Pharmacology Biochemistry and Behavior 99 (2), 164-189, 2011
412011
Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system
J Wang, S Carnicella, S Ahmadiantehrani, DY He, S Barak, V Kharazia, ...
The Journal of Neuroscience 30 (43), 14502-14512, 2010
362010
SAR110894, a potent histamine H3-receptor antagonist, displays procognitive effects in rodents
G Griebel, P Pichat, MP Pruniaux, S Beeské, M Lopez-Grancha, E Genet, ...
Pharmacology Biochemistry and Behavior 102 (2), 203-214, 2012
352012
The M1/M4 preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against …
S Barak, I Weiner
International Journal of Neuropsychopharmacology 14 (9), 1233-1246, 2011
342011
Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be …
S Barak, I Weiner
International Journal of Neuropsychopharmacology 12 (2), 227-241, 2009
342009
Positive autoregulation of GDNF levels in the ventral tegmental area mediates long-lasting inhibition of excessive alcohol consumption
S Barak, S Ahmadiantehrani, V Kharazia, D Ron
Translational psychiatry 1 (12), e60-e60, 2011
312011
Counterconditioning during reconsolidation prevents relapse of cocaine memories
K Goltseker, L Bolotin, S Barak
Neuropsychopharmacology 42 (3), 716-726, 2017
292017
GDNF is a novel ethanol‐responsive gene in the VTA: implications for the development and persistence of excessive drinking
S Ahmadiantehrani, S Barak, D Ron
Addiction biology 19 (4), 623-633, 2014
282014
The system can't perform the operation now. Try again later.
Articles 1–20